However, IHC findings on the association of ACKR4 protein expression with pathological findings have shown decreasing receptor immunopositivity along with increasing CRC stage and its lower expression in patients with lymph node metastasis [19]. The gene discussed is ACKR4; the disease is metastatic malignant neoplasm in the lymph nodes.